Develop and implement strategic and technical direction for commercialization of enabling technology platforms to manufacture and delivery medicines at the point of care.Create new capabilities and functionalities to enable a distributed “on demand” pharmaceuticals manufacturing paradigm that increases access to medicines, mitigates drug shortages, and strengthens the medicines supply chain.

Our proprietary algorithms drive market shaping analytics that tell the story behind your medicines

Launched the Medicines for All Institute in 2017 to improve access to affordable medicines. As M4ALL’s founding Executive Director, defined organizational priorities, led strategic direction, and positioned the institute as a sustainable entity.Developed and actualized strategy and business plans with revenue generation model, including staffing the organization—institute has added 30 research and administrative personnel to date.Built strategic partnerships to create and advance business opportunities that align with vision and mission—Developed partnerships with 11 global health organizations and country governments to collaborate on future drug targets for HIV, tuberculosis, malaria, and neglected diseases.Led and oversaw organization’s financials tracking and reporting systems and budgeting process; Created and implemented organizational and project tracking and reporting processes driven by milestones and deliverables.Oversaw and led the institute’s portfolio of projects and business lines—Served as project manager for $25M Bill & Melinda Gates Foundation grant.Led new technology development initiatives, including in-country manufacturing capabilities.Cultivated cross-team cohesion and improved efficiency and effectiveness across institute by developing process framework, optimization capacity models, and deliverable milestones for projects—developed hybrid culture of academic creativity with results-driven industry metrics.

Developed new program concepts and managed successful programs for DARPA on creation of biologically-inspired materials and adhesives (http://www.darpa.mil/NewsEvents/Releases/2014/06/05.aspx); development of distributed and miniaturized end-to-end manufacturing platform of multiple small-molecule organic pharmaceuticals using flow chemistry and protein therapeutics for on-demand applications (http://journal.pda.org/content/68/4/312.full.pdf+html); development of DARPA’s first synthetic biology effort applying engineering principles to build enabling end-to-end tool chains for design-build-test of novel biological systems; development of spectroscopic stand-off explosives detection technologies; as part of DARPA Technical Team, designed and developed of the 2007 DARPA Urban Challenge, the historical competition of self-driving vehicles in simulated urban traffic.Program and Capture Manager for two DoD multiple-award, indefinite-delivery/indefinite-quantity (IDIQ) contracts: -Homeland Defense and Security Technical Area Tasks (HD TATs, http://iac.dtic.mil/support_docs/hdtat_award_announcement.pdf), a $900 million multiple-award IDIQ contract providing research, development, test and evaluation, and advisory and assistance services for TATs within the chemical, biological, radiological and nuclear defense, homeland defense and security, critical infrastructure protection, weapons of mass destruction, biometrics, medical, cultural studies and alternative energy focus areas; and-Defense Systems Technical Area Tasks (DS TATs, http://iac.dtic.mil/support_docs/dstat_award_announcement.pdf), a $3 billion multiple-award IDIQ contract providing research, development, test and evaluation, and advisory and assistance services for technical area tasks within Advanced Materials.Served as Review Panelist for the National Science Foundation’s SBIR programs in Polymers and Biomaterials, Renewable Chemicals and Polymers, and Chemical and Polymer Technologies.

Developed, directed, and managed studies for the Department of Navy and Chief of Naval Operations providing independent, long-range, scientific and technical advice for the Navy and Marine Corps.Examined the policy, political, technical and operational implications of a global maritime partnership, including identifying force structure and interoperability needs.Analyzed experimentation and testing and evaluation capabilities of the Department of Defense on counter technologies against improvised explosive devices.

Co-authored a committee report on the review of the National Nanotechnology Initiative addressing program management assessment, benchmarking metrics, technology transfer and commercialization, and responsible development of nanotechnology.

Investigated biological systems for biomedical, bionanotechnology, and bioengineering applications using atomic force microscopy.Developed environmental and temperature controls, nanolithography capabilities, and surface modification techniques for atomic force microscopy applications.Resolved the molecular organization of individual rhodopsin (G protein-coupled receptor) molecules in the native disk membrane of the retinal rod cell and reconstituted lipid membrane system to improve understanding of cell-to-cell interactions.Probed the kinetic, structural, and mechanical properties of cytochrome c adsorption to lipid bilayers for potential applications for cell apoptosis.Investigated DNA-protein complexes known to play a critical role in gene regulation.Developed polydimethylsiloxane-based micro-fluidics technology for biological gradient applications to atomic force microscopy.Analyzed the conformational and organizational structure of amyloid-β peptide in Alzheimer’s disease.

Investigated protein adsorption ex situ and in situ under both static and dynamic conditions on various modified oligomeric and polymeric surfaces for prevention of thrombosis in biomaterials, medical devices, and biomedical applications.Investigated surfactant interactions with adsorbed proteins at surfaces.Synthesized and modified self-assembled monolayers on silicon, sapphire and glass substrates.Developed protocols for protein adsorption studies under dynamic conditions.Analyzed bio-polymeric materials surfaces using X-ray reflectometry, neutron reflectometry (in collaboration with National Institutes of Standards and Technology Center for Neutron Research), optical reflectometry (in collaboration with Carnegie Mellon University), atomic force microscopy, X-ray photoelectron spectroscopy, FTIR-ATR spectroscopy, Raman spectroscopy, contact angle, differential refractometry, and ellipsometry.Initiated collaborations and set up of experimental designs and ideas.